Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis and now Dime Bag and Syndicate, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Comment by shenry24on Oct 02, 2020 12:10am
221 Views
Post# 31656417

RE:RE:RE:RE:Any one catch the call??

RE:RE:RE:RE:Any one catch the call??

First, that $60mm estimate was snarkily thrown out there, and when dissected and refuted as "a much lower number", there was no additional contesting.   I will agree they had no clue what it might be, and I would have expected them to have such a figure prepared to give investors on this Q&A.

The loan is fully "drawn", but not spent.  I was under the impression they would "draw" on an "as needed" basis and only pay interest on that amount, so it was a bit of a disappointment to learn they got the 30 million cash and now have an additional annual expense of $4.5 million in interest.  

However, they sounded confident they are decreasing expenses, increasing revenue and will be on the path to cash positive in 2021.  

It wasn't all doom and gloom as your interpretation would suggest.  

<< Previous
Bullboard Posts
Next >>